1,091 results
Page 10 of 55
6-K
EX-99.1
aioo3 b46z
3 Sep 14
Live Filing
12:00am
6-K
EX-99.1
lle c5kqc139
3 Sep 14
Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca
12:00am
6-K
EX-99.1
tmm 5gmhpw
3 Sep 14
Teva Launches Syncaretm Home Administration Support Program for Patients on Synribo® (Omacetaxine Mepesuccinate) for Injection
12:00am
6-K
EX-99.1
mjakd1i2g9nn
2 Sep 14
Live Filing
12:00am
6-K
EX-99.1
v9w 7jl02rkw0a
7 Aug 14
Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) Formulation
12:00am
6-K
EX-99.1
oeijj223jw
21 Jul 14
Live Filing
12:00am
6-K
EX-99.1
4usnaesyl5749fx
14 Jul 14
First Breath-Actuated Dry-Powder SABA Inhaler to be Accepted by FDA for Review
12:00am
6-K
EX-99.1
k47v vg84dxulk5uk
3 Jul 14
Current report (foreign)
12:00am
6-K
EX-99.1
7eiw3noi6skfu
20 Jun 14
Teva Reaches Settlement In Proair®hfa Patent Case
12:00am
6-K
EX-99.1
cpx35npg46qy f2y1
17 Jun 14
Teva Reaches Settlements In Nuvigil® Patent Case
12:00am
6-K
EX-99.1
x2sp 1o666duqz
12 Jun 14
Teva Announces U.s. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® Patent
12:00am
6-K
EX-99.1
nfw51txarw 4y
9 Jun 14
FDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinson’s Disease
12:00am
6-K
EX-99.1
qrvnv8ka7 thc7
3 Jun 14
Live Filing
12:00am
6-K
EX-99.1
w292ry1w2mmoqguos59h
2 Jun 14
Appoints Sigurdur Olafsson As President and Ceo of Newly Established Global Generic Medicines Group
12:00am
6-K
EX-99.1
0zpoxvxomfh 1j21fxi
30 May 14
Teva Receives Favorable Court Decision Regarding Generic Celebrex ® Capsules; Teva should receive sole exclusivity for generic Celebrex ® Capsules
12:00am
6-K
EX-99.1
x1s6f5s
27 May 14
Teva Announces Favorable European Patent Office Ruling In COPAXONE® Patent Proceeding
12:00am
6-K
EX-99.1
nvpiod07 n6
23 May 14
Teva Received FDA Approval for QVAR® (beclomethasone dipropionate HFA) with Dose Counter
12:00am
6-K
EX-99.1
br4943v3ea5
29 Apr 14
Teva Receives European Marketing Authorization for DuoResp Spiromax® for the Treatment of Asthma and COPD
12:00am
6-K
EX-99.1
4mc21 wmqtwo0v8x
28 Apr 14
Live Filing
12:00am
6-K
EX-99.1
hhkkpfr2dgcwp0c 8hb
28 Apr 14
Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment In Japan
12:00am